Munich - Delayed Quote • EUR
Sarepta Therapeutics Inc (AB3A.MU)
As of 8:00 AM GMT+2. Market Open.
Loading Chart for AB3A.MU
DELL
- Previous Close
108.20 - Open
109.20 - Bid 109.35 x --
- Ask 110.40 x --
- Day's Range
109.20 - 109.20 - 52 Week Range
56.26 - 144.25 - Volume
30 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 30, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: AB3A.MU
Performance Overview: AB3A.MU
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
AB3A.MU
24.15%
S&P 500
5.05%
1-Year Return
AB3A.MU
4.67%
S&P 500
21.22%
3-Year Return
AB3A.MU
83.22%
S&P 500
21.18%
5-Year Return
AB3A.MU
4.96%
S&P 500
72.31%
Compare To: AB3A.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AB3A.MU
Valuation Measures
As of 4/22/2024
Market Cap
10.30B
Enterprise Value
10.04B
Trailing P/E
--
Forward P/E
40.82
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.57
Price/Book (mrq)
12.59
Enterprise Value/Revenue
8.07
Enterprise Value/EBITDA
-22.12
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: AB3A.MU
AB3A.MU does not have Company Insights